Amanda Gorman, the youngest inaugural poet in U.S. history, will read a piece she finished after the riot at the Capitol. "We’ve seen a force that would shatter our nation rather than share it," one line reads. nyti.ms/3is8cqP

In T'nysh Outs, @mikedicenzo collects Fran Lebowitz’s most helpful Amazon reviews: “I’ve never read ‘Harry Potter.’ I never will read ‘Harry Potter.’ Do you know why this is? Because I’m not 12.” nyer.cm/UIgbq5M

How can we improve #CART therapy for #Myeloma patients? We discussed with Lekha Mikkilineni of NIH: ow.ly/21xx50DlCN3 #ASH20 ASH #HemOnc #MultipleMyeloma #MMSM #ImmunoOnc #tcellrx

Miss Nola nytimes.com/2021/02/13/bus…

Huge day for MM therapy!! Congrats to all involved in the trials that lead to this landmark approval! fda.gov/news-events/pr…

The #NIH_Heme_Onc_Fellows have voted C. 'Harris' Floudas as our latest “Best Clinical Educator.” He designs & conducts immunotherapy-focused early-phase clinical trials for head and neck cancers and explores computational approaches to genomic data.

I think it’s especially important for our partners in industry and the cooperative groups to think more about this issue during site selection and trial design - aligning our clinical trial enrollment demographics with disease epidemiology is necessary #ASH21 BMT CTN

Pro tip: if you don’t want the winter solstice to feel like the shortest day of the year just call an insurance company’s appeals line

Being able to skillfully manage your attending should be a competency we measure in house officers.

Excited to highlight our research in Nature Medicine, which demonstrates that #antibiotic exposure and the gut #microbiome are linked to #CARTcell efficacy & toxicity. Stanford Department of Medicine Stanford BMT & Cell Therapy Memorial Sloan Kettering Cancer Center Penn Medicine Marcel van den Brink Marco Ruella #AndreaFacciabene

Listening to Stanford BMT & Cell Therapy Melody Smith, MD, MS discuss potential future areas of investment for ASTCT - looking forward to seeing some of these initiatives implemented soon to build the future of our society and the field #bmtsm #tcellrx #CARTcells #strategy

We identified factors that contribute to #burnout in hematologists and oncologists in the US and the are several potentially actionable steps. See the🧵below from ASH.

LIFE HISTORY of Investigator-initiated (sponsored) trial (IIT / IST) A🧵 Day 1. An idea. It came to you. Or came to your mentor. You saw something somewhere. Maybe it was @ASH or ASCO. You connected the dots. Month 1. You discuss it with your group. 1/19

Amazing!!!

Join me August 17 for the Society for Immunotherapy of Cancer #LearnACI live Cellular Therapies program featuring in-depth education on all aspects of cell therapies & T cell engagers. Register and invite a colleague: sitcancer.org/education/aci/…

We are thrilled to announce our new Chair of the Stanford Department of Medicine, Dr. Euan Ashley euan ashley . We have a great future ahead!!! Dr. Ashley becomes Chair Sept 18th, 2024.

Great to be a part of this team working to make CAR-T therapy safer for our patients.

.Stanford BMT & Cell Therapy is officially a 7-year Core Clinical Center! Kudos to Lori Muffly & the team for this prestigious recognition from the NIH NHLBI & National Cancer Institute. Here's to advancing groundbreaking research!

Celebrated hematologist Fred Appelbaum’s new book, Living Medicine, is part history, part biography — and a loving tribute to those who transformed a kernel of an idea into a lifesaving therapy and medical discipline: ow.ly/5rsY50SAo7i #BoneMarrowTransplant #BMT Lori Muffly